Np Test 2: Chest Disorders (Cardiac)

77 Questions | Total Attempts: 3676

SettingsSettingsSettings
Please wait...
Np Test 2: Chest Disorders (Cardiac)

.


Questions and Answers
  • 1. 
    You examine a 38-year-old woman who has presented for an initial examination and Pap test. She has no complaint. Her BP is 144/98 bilaterally and her body mass index is 31. The rest of her physical exam is unremarkable. Your next best action is to:
    • A. 

      Initiate hypertensive therapy

    • B. 

      Arrange for at least two additional BP measurements during the next 2 weeks

    • C. 

      Order her BUN, creatinine and potassium measurements and a UA

    • D. 

      Advise her to reduce her sodium intake

  • 2. 
    You see a 68-year-old woman as a patient who is transferring care to your practice. She has a 10-year history of hypertension, diabetes, and hyperlipidemia. Current medications include HCTZ, glipizide, metformin, simvastatin, and daily low-dose aspirin. Today's BP reading is 138/88 and the rest of her history and exam is unremarkable. Your next best action is to 
    • A. 

      Prescribe and ACE inhibitor

    • B. 

      Have her return for a BP recheck in 1 week

    • C. 

      Advise her that her current therapy is adequate

    • D. 

      Start and alpha adrenergic antagonist

  • 3. 
    You examine a 78-year-old woman with long-standing, poorly controlled hypertension. When evaluating her for hypertensive target organ damage, you look for evidence of:
    • A. 

      Lipid abnormalities

    • B. 

      Hyperinsulinemia and insulin resistance

    • C. 

      Left ventricular hypertrophy

    • D. 

      Clotting disorders

  • 4. 
    Diagnostic testing for a patient with new stage 1 primary HTN diagnosis should include all of the following except:
    • A. 

      Hct

    • B. 

      Uric acid

    • C. 

      Creatinine

    • D. 

      Potassium

  • 5. 
    In the person with HTN, which of the following would likely yield the greatest potential reduction in BP in a patient with a BMI of 30?
    • A. 

      10-kg weight loss

    • B. 

      Dietary sodium restriction to 2.4 g per day

    • C. 

      Regular aerobic physical activity, such as 30 minutes brisk walking most days

    • D. 

      Moderate alcohol consumption

  • 6. 
    Which of the following medications is a dihydropyridine calcium channel blocker?
    • A. 

      Lisinopril

    • B. 

      Verapamil

    • C. 

      Amlodipine

    • D. 

      Doxazosin

  • 7. 
    Which of the following medications is a nondihydropyridine calcium channel blocker?
    • A. 

      Lisinopril

    • B. 

      Diltiazem

    • C. 

      Amlodipine

    • D. 

      Prazosin

  • 8. 
    Which of the following medications is an alpha-adrenergic antagonist?
    • A. 

      Enalapril

    • B. 

      Diltiazem

    • C. 

      Felodipine

    • D. 

      Doxazosin

  • 9. 
    Which of the following medications is an ACEI
    • A. 

      Trandolapril

    • B. 

      Clonidine

    • C. 

      Felodipine

    • D. 

      Doxazosin

  • 10. 
    Which of the following medications is an angiotensin receptor antagonist?
    • A. 

      Trandolapril

    • B. 

      Methyldopa

    • C. 

      Telmisartan

    • D. 

      Atenolol

  • 11. 
    Which of the following medications is a beta-adrenergic receptor antagonist?
    • A. 

      Clonidine

    • B. 

      Spironolactone

    • C. 

      HCTZ

    • D. 

      Pindolol

  • 12. 
    The mechanism of action of aliskiren (Tekturna) is as a/an:
    • A. 

      ACEI

    • B. 

      Beta-adrenergic antagonist

    • C. 

      Centrally acting agent

    • D. 

      Direct renin inhibitor

  • 13. 
    In obtaining an office BP measurement, which of the following is most reflective of the Seventh Report of the National High Blood Pressure Education Program for the Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC-7) recommendations?
    • A. 

      Patient should sit in chair with feet flat on floor for at least 5 minutes before obtaining a reading

    • B. 

      The BP cuff should not cover more than 50 % of the upper arm

    • C. 

      The patient should sit on the edge of the examination table without arm support to enhance reading accuracy.

    • D. 

      Obtaining the BP reading immediately after the patient walks into the exam room is recommended.

  • 14. 
    A BP elevation noted only at an office visit is commonly known as __________ hypertension
    • A. 

      Provider-induced

    • B. 

      Clinical

    • C. 

      White coat

    • D. 

      Pseudo

  • 15. 
    The most important goal of treating HTN is to:
    • A. 

      Strive to reach recommended numeric BP measurement

    • B. 

      Avoid disease-related target organ damage

    • C. 

      Develop a plan of care with minimal adverse effects

    • D. 

      Treat concomitant health problems often noted in the person with this condition

  • 16. 
    You start a patient with hypertension who is already receiving an ACEI on sprionolactone. You advise the patient to return in 4 weeks to check which of the following lab parameters?
    • A. 

      Sodium

    • B. 

      Calcium

    • C. 

      Potassium

    • D. 

      Chloride

  • 17. 
    A 68-year-old woman presents with HTN and a BP of 145-155 / 92-96 mmHG documented over 2 months on three different occasions. ECG and creatinine are normal, and she has no proteinuria. Clinical findings include the following: BMI 26.4; no S3, S4, or murmur; and point of maximal impulse at the 5th intercostal space, mid-clavicular line. Wich of the following represents the best intervention.
    • A. 

      Initiate therapy with atenolol

    • B. 

      Initiate therapy with HCTZ

    • C. 

      Initiate therapy with methyldopa

    • D. 

      Continue to monitor BP and start drug therapy if evidence of target organ damage.

  • 18. 
    Which of the following can have a favorable effect on a comorbid condition in a person with HTN?
    • A. 

      Chlorthalidone in gout

    • B. 

      Propranolol with airway disease

    • C. 

      Verapamil in migraine headaches

    • D. 

      Methyldopa in an older adult

  • 19. 
    According to the recommendations found in JNC-7, all of the following medications are designated as having a compelling indication for use in the person with high cardiovascular disease risk except:
    • A. 

      Doxazosin

    • B. 

      HCTZ

    • C. 

      Atenolol

    • D. 

      Trandolapril

  • 20. 
    You see a 59-year-old man with poorly controlled HTN. On physical exam, you note grade 1 hypertensive retinopathy. You anticipate all of the following will be present except:
    • A. 

      Patient report of acute visual change

    • B. 

      Narrowing of the terminal arterioles

    • C. 

      Sharp optic disc borders

    • D. 

      Absence of retinal hemorrhage

  • 21. 
    A 52-year-old woman whose BP is consistently 130-135 / 82-86 mmHG who is otherwise well is considered to have:
    • A. 

      Normal BP

    • B. 

      Prehypertension

    • C. 

      Stage 1 HTN

    • D. 

      Stage 2 HTN

  • 22. 
    Which medication(s) are listed as compelling indications for heart failure?
    • A. 

      Thiazide Diuretic

    • B. 

      Beta blocker

    • C. 

      ACEI

    • D. 

      ARB

    • E. 

      Aldosterone antagonist

    • F. 

      Calcium channel blocker

  • 23. 
    Which medication(s) are listed as compelling indications for Diabetes?
    • A. 

      Thiazide diuretic

    • B. 

      Beta blocker

    • C. 

      ACEI

    • D. 

      ARB

    • E. 

      Aldosterone antagonist

    • F. 

      Calcium channel blocker

  • 24. 
    Which medication(s) are listed as compelling indications for Chronic renal disease?
    • A. 

      Thiazide diuretic

    • B. 

      Beta Blocker

    • C. 

      ACEI

    • D. 

      ARB

    • E. 

      Aldosterone Antagonist

    • F. 

      Calcium channel blocker

  • 25. 
    Which medication(s) are listed as compelling indications for high risk CAD?
    • A. 

      Thiazide diuretic

    • B. 

      Beta blocker

    • C. 

      ACEI

    • D. 

      ARB

    • E. 

      Aldosterone antagonist

    • F. 

      Calcium channel blocker

Back to Top Back to top